STOOLOMX TEST – ADVANCED ANALYSIS OF INTESTINAL METABOLOME
StoolOMX™ is an advanced functional test that analyzes metabolites produced by the gut microbiota, providing insights into microbiome activity, digestive health, metabolism, and immune balance. By evaluating Short-Chain Fatty Acids (SCFAs) and Bile Acids (BAs), the test helps identify intestinal imbalances and supports personalized therapeutic strategies.
StoolOMX™ is an advanced functional test designed to evaluate the metabolic activity of the gut microbiome by analyzing metabolites produced by intestinal bacteria. Using high-precision LC-MS/MS technology, the test measures the profile of Short-Chain Fatty Acids (SCFAs) and Bile Acids (BAs), providing valuable insights into digestive, metabolic, and immune health.
Unlike traditional microbiome analyses, which identify the microorganisms present in the gut, StoolOMX™ evaluates what the microbiota produces and how these substances influence the body. As a result, the test offers a functional perspective on the intestinal ecosystem and the relationship between the microbiome, inflammation, metabolism, and the immune system.
What Does the Test Analyze?
Short-Chain Fatty Acids (SCFAs)
SCFAs are metabolites produced through the fermentation of dietary fibers by beneficial intestinal bacteria. They play an essential role in:
▪️ Maintaining intestinal barrier integrity
▪️ Supporting immune function
▪️ Regulating inflammation
▪️ Intestinal energy metabolism
▪️ Communication between the gut and the brain
Bile Acids (BAs)
Bile acids are involved not only in fat digestion but also in the regulation of metabolism and inflammatory processes. Their analysis can provide information about:
▪️ Liver and biliary function
▪️ Lipid metabolism
▪️ The interaction between the microbiome and the liver
▪️ Intestinal inflammatory processes
▪️ Microbiome-associated metabolic imbalances
When Is StoolOMX™ Recommended?
The test may be beneficial for individuals experiencing:
▪️ Irritable Bowel Syndrome (IBS)
▪️ Bloating, gas, and abdominal discomfort
▪️ Increased intestinal permeability ("Leaky Gut")
▪️ Inflammatory bowel diseases
▪️ Insulin resistance and metabolic syndrome
▪️ Liver conditions or biliary dysfunction
▪️ Autoimmune and chronic inflammatory conditions
▪️ Chronic fatigue associated with microbiome imbalances
StoolOMX™ can also be used to monitor the response to nutritional interventions, probiotics, prebiotics, and microbiome restoration programs.
Benefits of StoolOMX™
▪️ Advanced functional assessment of the gut microbiome
▪️ Identification of metabolic imbalances that may not be detected through standard microbiological testing
▪️ Personalization of nutritional recommendations and therapeutic strategies
▪️ Monitoring the effectiveness of microbiome-focused interventions
▪️ Better understanding of the relationship between the microbiome, inflammation, and metabolic health
StoolOMX™ + GI-MAP
For a comprehensive assessment of intestinal health, StoolOMX™ can be performed alongside the GI-MAP test. While GI-MAP identifies the microorganisms present in the gut, StoolOMX™ evaluates their metabolic activity, providing a broader understanding of microbiome function and its impact on overall health.
For more information about the test and result interpretation, please contact the Quantica720° team.